Shared Decision Making to Address Racial Disparities in Oral Anticoagulation in NVAF

Starting soon · Not applicable

Conditions studied: Atrial Fibrillation

In brief

The study is a pilot analysis using a decision on the risk and benefits of oral anticoagulation for stroke reduction for patients with non-valvular atrial fibrillation. This study is a feasibility and acceptability analysis but will also measure preliminary effectiveness measures. The investigator hypothesizes that a patient decision support tool will increase decision quality and secondarily increase the use of oral anticoagulation in Black patients with non-valvular atrial fibrillation.

Key facts

Study ID

NCT04956978

Run by

Duke University

People needed

40

Starts

2026-06-01

Expected to finish

2026-12-31

Last updated by the study team

2026-03-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Black and White adults greater than or equal to 18 years of age
• Clinical diagnosis of NVAF
• CHA2DS2-VASc score greater than or equal to 2
• New patient visit for initiation of oral anticoagulation at primary care and cardiology clinics

You may not qualify if…

• Unable to speak English
• Unable to provide informed consent

Where it is running

• Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.